| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 02/07/2023 | 90.11% | HC Wainwright & Co. | → $15 | Reiterates | → Buy |
| 11/11/2022 | 90.11% | HC Wainwright & Co. | $14 → $15 | Maintains | Buy |
| 05/17/2022 | 77.44% | HC Wainwright & Co. | $16 → $14 | Maintains | Buy |
| 03/31/2022 | 102.79% | HC Wainwright & Co. | $15 → $16 | Maintains | Buy |
| 01/14/2022 | 90.11% | HC Wainwright & Co. | $12 → $15 | Maintains | Buy |
| 12/20/2021 | 52.09% | HC Wainwright & Co. | → $12 | Initiates Coverage On | → Buy |
| 10/13/2021 | — | Dawson James | Downgrades | Buy → Neutral |
What is the target price for ProPhase Labs (PRPH)?
The latest price target for ProPhase Labs (NASDAQ: PRPH) was reported by HC Wainwright & Co. on February 7, 2023. The analyst firm set a price target for $15.00 expecting PRPH to rise to within 12 months (a possible 90.11% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for ProPhase Labs (PRPH)?
The latest analyst rating for ProPhase Labs (NASDAQ: PRPH) was provided by HC Wainwright & Co., and ProPhase Labs reiterated their buy rating.
When is the next analyst rating going to be posted or updated for ProPhase Labs (PRPH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ProPhase Labs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ProPhase Labs was filed on February 7, 2023 so you should expect the next rating to be made available sometime around February 7, 2024.
Is the Analyst Rating ProPhase Labs (PRPH) correct?
While ratings are subjective and will change, the latest ProPhase Labs (PRPH) rating was a reiterated with a price target of $0.00 to $15.00. The current price ProPhase Labs (PRPH) is trading at is $7.89, which is within the analyst's predicted range.